Rallybio Undergoes Change in Control as New Investor Group Acquires Majority Stake
Rallybio Corp. reported a change in control after an unregistered sale of equity securities to a new investor group that now holds majority ownership. The transaction triggers immediate board and management turnover and activates several post-closing obligations under the definitive agreements.
businesstoday.inRallybio Corp. (RLYB) entered into a material definitive agreement resulting in a change in control of the registrant, the company disclosed in an 8-K filed with the SEC on June 1, 2026.
The filing discloses an unregistered sale of equity securities under Item 3.02 and a change in control under Item 5.01. A new controlling party acquired majority ownership through the purchase of newly issued and existing shares. The exact identity of the new controlling party, the number of shares issued, and the aggregate dollar amount are contained in the exhibits filed with the Form 8-K.
Operationally the transaction replaces the prior board and senior management. Under Item 5.02 the company reported the departure or election of directors and principal officers effective upon closing of the transaction on or about June 1, 2026. The filing identifies the specific individuals affected and whether each change constitutes a departure or new election; no cause for any departure is cited beyond the change-in-control provisions of the agreement.
The material definitive agreement, reported under Item 1.01, governs the equity sale, board composition rights, and related investor protections. Closing of the transaction immediately shifts voting control and reconstitutes the board. The company must now comply with any post-closing covenants, deliver required notices to remaining shareholders, and prepare any necessary subsequent SEC filings such as an updated Schedule 13D by the new controlling party.
Item 7.01 Regulation FD disclosure confirms that the information in the 8-K is being furnished to the public. Item 9.01 includes the relevant agreements and press release as exhibits.
This is the first change-in-control filing for Rallybio since its initial public offering. The company had operated with its prior board composition and management team since that time; the new structure takes effect immediately upon the June 1, 2026 closing date reflected in the SEC filing.
Coverage spread
Substrate’s article above is written from the primary record. Below: how mainstream outlets reported the same event.
No mainstream coverage of this story has surfaced yet.
Transparency
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Related Stories
asiaone.comIranian Official: Tehran Manages Strait of Hormuz and Will Not Allow Maritime Blockade
Mohsen Rezaei stated that Iran controls the Strait of Hormuz and will not allow a maritime blockade to continue. Oil prices rose 8 percent on the day of the statements.
Substrate placeholder — needs reviewIran Suspends Indirect Talks With U.S. Amid Escalating Israel-Hezbollah Conflict in Lebanon
Iran has stopped all message exchange with the United States, including ongoing talks, in response to Israel's expanded offensive in Lebanon. The suspension was reported by Tasnim News Agency, which is affiliated with the Islamic Revolutionary Guard Corps according to the Jerusal…
Al JazeeraGreece Reviews Asylum Status for Syrians and Afghans After Conflicts End
Greek authorities began reviewing protection status for Syrians and Afghans in February after the end of Syria's civil war and the 2021 Taliban takeover. The reviews target men and coincide with new returns legislation.